{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-156043","form_type":"8-K","ticker":"TEVA","cik":"0000818686","company_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","filed_at":"2024-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.069501+00:00","generated_at":"2026-06-01T06:06:41.880267+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Teva shareholders elect four directors, approve say-on-pay and auditor at annual meeting","bullets":["Elected Prof. Varda Shalev to board through 2026; Rosemary Crane, Gerald Lieberman, Prof. Ronit Satchi-Fainaro through 2027.","Non-binding advisory vote on executive compensation approved: 571,822,049 for vs 120,609,632 against.","Shareholders recommended annual advisory vote on exec comp (one-year frequency) with 536,980,720 votes.","Ratification of Kesselman & Kesselman (PwC) as independent auditor approved: 731,150,255 for, 30,335,560 against."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-156043","json":"https://secwatch.observer/filing/0001193125-24-156043.json","markdown":"https://secwatch.observer/filing/0001193125-24-156043.md","text":"https://secwatch.observer/filing/0001193125-24-156043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818686/000119312524156043/0001193125-24-156043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818686/000119312524156043/d841419d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:06:41.880267+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}